Citations are updated once a week. Recently added citations may not appear.
Context | Citation |
---|---|
Streptococcus salivarius K12 |
?
A concerted probiotic activity to inhibit periodontitis-associated bacteria. PloS one (PLoS One ) Vol: 16 Issue 3 Pages: e0248308 Pub: 2021 Epub: 2021 Mar 5 Authors Jansen PM , Abdelbary MMH , Conrads G , Html Article Publication |
Streptococcus salivarius K12 |
?
Mitigation of the Toxic Effects of Periodontal Pathogens by Candidate Probiotics in Oral Keratinocytes, and in an Invertebrate Model. Frontiers in microbiology (Front Microbiol ) Vol: 11 Issue Pages: 999 Pub: 2020 Epub: 2020 Jun 16 Authors Moman R , O`Neill CA , Ledder RG , Cheesapcharoen T , McBain AJ , Html Article Publication |
Streptococcus salivarius K12 |
?
Influence of Probiotic Culture Supernatants on In Vitro Biofilm Formation of Staphylococci. European journal of microbiology & immunology (Eur J Microbiol Immunol (Bp) ) Vol: 8 Issue 4 Pages: 119-127 Pub: 2018 Dec 23 Epub: 2018 Sep 28 Authors Frickmann H , Klenk C , Warnke P , Redanz S , Podbielski A , Html Article Publication |
Streptococcus salivarius K12 |
?
Streptococcus salivarius inhibits immune activation by periodontal disease pathogens. BMC oral health (BMC Oral Health ) Vol: 21 Issue 1 Pages: 245 Pub: 2021 May 7 Epub: 2021 May 7 Authors MacDonald KW , Chanyi RM , Macklaim JM , Cadieux PA , Reid G , Burton JP , Html Article Publication |
Streptococcus salivarius K12 |
?
In vitro Interactions between Streptococcus intermedius and Streptococcus salivarius K12 on a Titanium Cylindrical Surface. Pathogens (Basel, Switzerland) (Pathogens ) Vol: 9 Issue 12 Pages: Pub: 2020 Dec 20 Epub: 2020 Dec 20 Authors Vacca C , Contu MP , Rossi C , Ferrando ML , Blus C , Szmukler-Moncler S , Scano A , Orrù G , Html Article Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.